Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ESMO Open
Journal
Overview
Identity
Overview
Publication Venue For
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
. 6.
2021
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
. 5.
2020
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
. 1.
2016
Identity
Electronic International Standard Serial Number (eissn)
2059-7029
